{"url":"https://lda.senate.gov/api/v1/filings/2bc20479-dcdf-4bb9-9290-8ecdffa2029d/","filing_uuid":"2bc20479-dcdf-4bb9-9290-8ecdffa2029d","filing_type":"RR","filing_type_display":"Registration","filing_year":2024,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2bc20479-dcdf-4bb9-9290-8ecdffa2029d/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Bryan Shuy","dt_posted":"2025-01-02T17:17:16-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 Pennsylvania Ave, NW","registrant_address_2":"13th Floor North","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401004840,"url":"https://lda.senate.gov/api/v1/registrants/401004840/","house_registrant_id":null,"name":"THE CONAFAY GROUP, LLC","description":"Life Sciences Consulting Firm","address_1":"1717 K St., NW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERICA WOODWARD","contact_telephone":"+1 859-229-7237","dt_updated":"2026-07-30T09:45:36.196045-04:00"},"client":{"id":63356,"url":"https://lda.senate.gov/api/v1/clients/63356/","client_id":63356,"name":"REALTA LIFE SCIENCES, INC.","general_description":"A life sciences company creating novel therapeutic drugs.","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-12-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocating for patient access to novel HIE therapeutics.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64541,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"P.","last_name":"PAWELCZYK","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":143511,"prefix":null,"prefix_display":null,"first_name":"BRYAN","nickname":null,"middle_name":null,"last_name":"SHUY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmteon Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst.Secretary for Preparedness and Response (ASPR)","new":true}],"government_entities":[]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Advocating for patient access to novel HIE therapeutics.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64541,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"P.","last_name":"PAWELCZYK","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":143511,"prefix":null,"prefix_display":null,"first_name":"BRYAN","nickname":null,"middle_name":null,"last_name":"SHUY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmteon Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst.Secretary for Preparedness and Response (ASPR)","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}